JAMA Dermatology

Article	Citations
JAMA Dermatology	802
Perceptions of US-Based Muslim Patients of Their Dermatology Care	378
Treatment of Verruca Plana With Topical Combination of Calcipotriol and Fluorouracil	328
Error in Author Name	235
Error in Author Surname in Byline	182
Widespread Erythematous Plaques With Prominent Telangiectases	152
Treatment With Topical Sirolimus for Recurrent Lymphatic Malformation of the External Urethral Meatus	151
Clinical and Pathological Spectrum of Prurigo Pigmentosa in Central European Individuals	140
Frequency of Skin Biopsies for Psoriasis by Race and Ethnicity	127
Exanthematous Eruption in a Patient With Known Chronic Graft-vs-Host Disease and Recent Measles Vaccination	123
JAMA Dermatology	110
Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database	106
Melanoma Screening	104
Can Serum Biomarkers for Prurigo Nodularis Expose Pathophysiology or Just Treatment Response?	100
Incidence, In-Hospital and Long-Term Mortality, and Sequelae of Epidermal Necrolysis in Adults	86
Recurrence Rate of Melanoma In Situ Excised With a 5-mm Excisional Margin	84
Tofacitinib for Treatment of Acquired Reactive Perforating Collagenosis	81
Novel Treatments for Chronic Erythema Multiforme Inform Translational Science and Disease Pathogenesis	78
Association of Treatment With Secukinumab With Exacerbation of Dermatomyositis in a Patient With Psoriasis	76
Treatment of Severe Palmoplantar Pustular Psoriasis With Bimekizumab	75
Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records	72
Low-Dose Metformin and Profibrotic Signature in Central Centrifugal Cicatricial Alopecia	71
Prevalence of Contact Allergens in Natural Skin Care Products From US Commercial Retailers	69
Current State of Dermatology Mobile Applications With Artificial Intelligence Features	63
Immune Checkpoint Inhibitors in Field Cancerization and Keratinocyte Cancer Prevention	62

Adalimumab Monotherapy vs Adalimumab With Methotrexate for Psoriasis	61
Group Omitted From Article Byline	60
Subclinical Synovitis Among Patients With Psoriasis Without Musculoskeletal Involvement	59
Biomarkers of Tretinoin Precursors and Tretinoin Efficacy in Patients With Moderate to Severe Facial Photodamage	57
Treatment of Kimura Disease With Dupilumab	56
Smoking Cessation and Risk of Hidradenitis Suppurativa Development	55
Treatment With Ataluren for Wound Healing and Health Complications in a Patient With Junctional Epidermolysis Bullosa	52
Patient-Reported Outcomes in Dermatology	50
Alopecia Areata	49
Outcomes Associated With Combination Shaving and Cryosurgery Treatment in Patients With Keloid Scars	49
Ultraprocessed Food Intake and Psoriasis	49
Association of Persistent Rubella Virus With Idiopathic Skin Granulomas in Clinically Immunocompetent Adults	48
Pregabalin for Neuropathic Pain and Itch in Recessive Dystrophic Epidermolysis Bullosa	48
Skin Cancer Care in US Veterans—Serving Those Who Served	48
Parental E-Cigarette Use and Pediatric Atopic Dermatitis	47
Cutaneous Angiosarcoma	46
Prevalence and Patient Characteristics of Ectodermal Dysplasias in Denmark	43
Assessment of Cutaneous Vasculitis and Quality of Life	42
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice	42
COVID-19 as a Risk Factor For Autoimmune Skin Disease	41
The Quest for a More Accurate Diagnosis of Cellulitis	41
ALK-Positive Histiocytosis—A Distinct Histiocytic Entity Deserving Recognition—Reply	41
Cooling Research Fever in Dermatology—The Role of Community Service—Reply	41
Methotrexate and Interstitial Lung Disease—Reply	40
Considerations Regarding Mohs Surgery for Early-Stage Merkel Cell Carcinoma	40
Serum Immunoglobulin G Levels and Nicastrin Variation in Hidradenitis Suppurativa	39
JAMA Dermatology	39
Association of Demographic Factors and Infantile Hemangioma Characteristics With Risk of PHACE Syndrome	39
Spesolimab Response in a Patient With Steroid-Resistant Sweet Syndrome	38
Alectinib In the Treatment of Systemic Juvenile Xanthogranuloma of Infancy With ALK Translocation	38
Errors in Abstract, Results, and Table 1	37
Clinical Evidence on “Watchful Waiting” in Basal Cell Carcinoma	37
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis—Coordinating Research Priorities to Move the Field Forward	36
Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones	36
Reexamining Medication Impact in Hidradenitis Suppurativa and Pregnancy—Reply	36
Rapid Improvement in Refractory Acute Generalized Exanthematous Pustulosis With Spesolimab	36
Antihypertensive Medications and Eczematous Dermatitis in Older Adults	35
Lesbian, Gay, Bisexual, and Transgender Identity and Disclosure Among Dermatologists in the US	34
Foscarnet-Induced Penile Ulceration	34
Trends in the Prevalence of Eczema Among US Children by Age, Sex, Race, and Ethnicity From 1997 to 2018	33
Mohs Surgery vs Wide Local Excision in Primary High-Stage Cutaneous Squamous Cell Carcinoma	33
Validation of the 2022 National Comprehensive Cancer Network Risk Stratification for Cutaneous Squamous Cell Carcinoma	33
Cardiovascular and Venous Thromboembolic Risk With JAK Inhibitors in Immune-Mediated Inflammatory Skin Diseases	33
Federated Learning for Decentralized Artificial Intelligence in Melanoma Diagnostics	33
Validation of Case Identification for Melasma Using International Statistical Classification of Diseases and Related Health Problems, Tenth Revision Codes	32
Treatment of Severe Dermatitis, Multiple Allergies, and Metabolic Wasting With Dupilumab	32
Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa	31
Communication Between Dermatologists and Dermatopathologists via the Pathology Requisition	31
Clinical Characteristics Associated With Response to Biologics in the Treatment of Psoriasis	31
Characterizing the Clinical Implications of Histologic Regression in Melanoma Requires Clear Diagnostic Criteria That Are Consistently Applied	30

Numerous Angiomatous Lesions in an Infant	30
Chloracne	30
A Tribute to Samuel Moschella	30
Error in Figure 1	30
Errors in Figure 2 and Table 2 Footnotes	30
Incidence of and Risk Factors for Keratinocyte Carcinoma After Pediatric Solid Organ Transplant	29
A Firm Pigmented Plaque on the Forearm of a Child	29
Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body	28
Melanoma and Racial Health Disparities in Black Individuals—Facts, Fallacies, and Fixes	28
Research Fever in Dermatology—A Symptom of a Larger Problem	28
Chemotherapy-Induced Pseudocellulitis Without Prior Radiation Exposure	28
Oral Lichenoid Lesions Associated With Mediastinal Mass and Hypogammaglobulinemia in a Middle-aged Man	27
JAMA Dermatology Peer Reviewers in 2022	27
Incorporating Social Determinants of Health Into Medical Decision-making—Implications for Dermatology	27
Association of Different Prescribing Patterns for Oral Corticosteroids With Fracture Preventive Care Among Older Adults in the UK and Ontario	27
Error in Table	26
Billing Patterns and Geographic Distribution of Dermatologist-Dermatopathologists in the US From 2013 to 2017	26
Legislative Efforts Restricting Care for Transgender People	26
A Case of Unilateral Focal Hyperkeratosis	26
Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea	25
Use of Patient-Reported Outcomes in Acne Vulgaris and Rosacea Clinical Trials From 2011 to 2021	25
History, Diagnosis, Pathogenesis, and Nomenclature in Sublamina Densa-Type Linear IgA Disease	25
Dermatologist Workforce Mobility	25
Skin Cancer Risk Factors and Screening Among Asian American Individuals	25
Incidence and Prevalence of Morphea	25
JAMA Dermatology	25
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus	25
Cytotoxic T-Lymphocyte Antigen–4 Haploinsufficiency Cutaneous Manifestations	24
Evaluation of Watchful Waiting and Tumor Behavior in Patients With Basal Cell Carcinoma	24
Risk of New-Onset and Recurrent Depression and Anxiety Among Patients With Hidradenitis Suppurativa	24
Safety and Efficacy of Topical Lovastatin Plus Cholesterol Cream vs Topical Lovastatin Cream Alone for the Treatment of Disseminated Superficial Actinic Porokeratosis	24
The Genomic and Phenotypic Landscape of Ichthyosis	24
Errors in Abstract and Results Section	24
High-Dose Upadacitinib Therapy for Refractory Metastatic Crohn Disease	24
Association of Sun-Protective Behaviors With Bone Mineral Density and Osteoporotic Bone Fractures in US Adults	24
CLOVES Syndrome	23
Differences in Face-to-Face Time Spent With a Dermatologist Among Patients With Psoriasis Based on Race and Ethnicity	23
Prevalence of Comorbidities Among Pediatric Patients With Hidradenitis Suppurativa	23
Error in Table Footnote	23
Use of Reflectance Confocal Microscopy in Equivocal Lesions for the Diagnosis of Melanoma	23
Mendelian Randomization for Dermatology Research	23
Epidermolysis Bullosa Pruriginosa Treated With Upadacitinib	23
Xeroradiography as a Noninvasive Tool in Diagnosing Calciphylaxis	23
Recurrence Rate of Small Melanoma In Situ on Low-Risk Sites Excised With 5-mm Excisional Margin	23
Role of Eosinophils in Angiolymphoid Hyperplasia With Eosinophilia	23
Association of Facial Pustular Neutrophilic Eruption With Messenger RNA–1273 SARS-CoV-2 Vaccine	22
Consent and Identifiability for Patient Images in Research, Education, and Image-Based Artificial Intelligence	22
Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy	22
Recurring Papules and Nodules on the Vulva	22
Association of Biologic Treatment in Hidradenitis Suppurativa With Reduced Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio	22
Successful Treatment of Stimulator of Interferon Genes–Associated Vasculopathy of Infantile Onset SAVI Syndrome With Anifrolumab	22
Outcomes Associated With Neutropenia and Lymphopenia in Epidermal Necrolysis	22
Symptoms of Cognitive Impairment Among Children With Atopic Dermatitis	22
Skin-Related Quality of Life During Autoimmune Bullous Disease Course	22
Potential Sexual Transmission of Tinea Pubogenitalis From TMVII	21
Benign Familial Pemphigus in Skin of Color	21
Cutaneous Herpetiform Ulcerations as the Presenting Sign of an Acute Aortic Occlusion	21
Clinical and Serological Characterization of Orf-Induced Immunobullous Disease	21
Doxycycline Postexposure Prophylaxis (DoxyPEP) for Bacterial STI Prevention	21
Annular Erythematous Eruption in a Pediatric Patient	21
Evaluation of Gabapentin and Transforaminal Corticosteroid Injections for Brachioradial Pruritus	21
Artificial Intelligence and Dermatology	20
Sudden Conjunctivitis, Lymphopenia, and Rash Combined With Hemodynamic Changes (SCoRCH) After Trimethoprim-Sulfamethoxazole Use	20
Palmar Fasciitis and Polyarthritis Syndrome	20
CLAPO Syndrome	20
Eruptive Xanthomas	20
Evaluation of Thalidomide Treatment of Patients With Chronic Erythema Multiforme	20
Assessment of Need for Improved Identification of a Culprit Drug in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis	20
Molecular and Clinical Outcomes After Intravenous Gentamicin Treatment for Patients With Junctional Epidermolysis Bullosa Caused by Nonsense Variants	20
Smooth, Firm, Skin-Colored Papules on the Nasal Dorsum	20
Acrodermatitis Enteropathica	19
The Importance of Hair in Black−White Race Relations	19
Projective Personification Approach to the Experience of People With Acne and Acne Scarring—Expressing the Unspoken	19
Safety and Efficacy of Anti–IL-23 Monoclonal Antibody QX004N for Patients With Psoriasis	19
Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia Areata	19
Evaluation and Treatment of Febrile Ulceronecrotic Mucha-Habermann Disease With Ruxolitinib and Tocilizumab as Guided by Cytokine Profile	19
Fibromyalgia in Patients With Hidradenitis Suppurativa	19
Comorbidities of Keloid and Hypertrophic Scars Among Participants in UK Biobank	19
Cost-Utility Analysis of Rituximab vs Mycophenolate Mofetil for the Treatment of Pemphigus Vulgaris	18
Diversity and Career Goals of Graduating Allopathic Medical Students Pursuing Careers in Dermatology	18

Epitope Spreading in Immune Checkpoint Inhibitor–Associated Bullous Pemphigoid	18
Differences Between Children and Adults With Hidradenitis Suppurativa	18
Patient Perspectives on the Lived Experience of Acne and Its Treatment Among Adult Women With Acne	18
JAMA Dermatology Peer Reviewers in 2024	18
JAMA Dermatology	18
Characterizing Chronic Cutaneous Immune-Related Adverse Events Following Immune Checkpoint Inhibitors	18
Lack of Transparency and Potential Bias in Artificial Intelligence Data Sets and Algorithms	17
Outcomes of COVID-19 and Vaccination in Patients With Moderate to Severe Atopic Dermatitis Treated With Tralokinumab	17
Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa	17
Content Analysis of Patient-Reported Outcome Measures Used in Patients With Nail Conditions	17
Geographic Distribution and Workforce Diversity of Dermatology Physician Assistants—Reply	17
Outpatient Dermatology Productivity Measures by Patient Race, Sex, and Age	17
Prevalence of Pretreatment Testing Recommended for Patients With Chronic Inflammatory Skin Diseases	16
Genetic Susceptibility to Hidradenitis Suppurativa and Predisposition to Cardiometabolic Disease	16
Painful Palmar and Plantar Purpura	16
Assessing the Potential for Patient-led Surveillance After Treatment of Localized Melanoma (MEL-SELF)	16
Radiation Recall Dermatitis With Bruton Tyrosine Kinase Inhibitor Therapy	16
Patient Perspectives on Living With Severe Prurigo Nodularis	16
Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis	16
Rubella Virus–Associated Granulomas in Immunocompetent Adults—Possible Implications	16
Eruptive Acral Nevi Secondary to Treatment With Chemotherapy	16
Diagnosis of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors	16
Treatment of Netherton Syndrome With Abrocitinib	16
A Reddish Semitransparent Tumor in an Adolescent Girl	16
Granulomatous Cheilitis in a Young Woman	16
Response of Severe Lupus Miliaris Disseminatus Faciei to Treatment With Ruxolitinib Cream	15
JAMA Dermatology	15
Delphi Panel for the Development of Diagnostic Criteria for Metastatic Cutaneous Crohn Disease	15
Global Applicability of a Risk Prediction Tool for Sentinel Node Positivity in Patients With Primary Cutaneous Melanoma	15
Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis	15
Granulomatosis With Polyangiitis Presenting With Strawberry Gums	15
Adjuvant Immunotherapy in Stage II Melanoma—Further Risk Stratification is Needed	15
Improvement of Hailey-Hailey Disease With Topical Cinacalcet, 3%, Ointment	15
Safety and Effectiveness of Oral Nutraceuticals for Treating Acne	15
Generalized Micropapular Eruption in a Teenager	14
Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis	14
JAMA Dermatology	14
UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS Syndrome	14
Nonmelanoma Skin Cancer in Patients Older Than Age 85 Years Presenting for Mohs Surgery	14
Pigmentary Changes in a Woman With Oral Lichen Planus	14
Association Between Psoriasis and Nonalcoholic Fatty Liver Disease Among Outpatient US Adults	14
Reanalysis Following Removal of Participants From 1 Site in Multicenter Trial of Upadacitinib vs Dupilumab for Atopic Dermatitis	13
Error in Box	13
Treatment of Porokeratosis Ptychotropica With a Topical Combination of Cholesterol and Simvastatin	13
Pyoderma Gangrenosum	13
JAMA Dermatology	13
Tuberculous Mastitis	13
Chronic Mucocutaneous Candidiasis Due to STAT1 Gene Variant	13
Health-Related Quality of Life, Depression, and Self-esteem in Patients With Androgenetic Alopecia	13
Response of Widespread Generalized Essential Telangiectasia Following Treatment With Oral Dabigatran	13
Hypertrophic Tongue Papillae in Cowden Syndrome/PTEN Hamartoma Tumor Syndrome	13
Perspectives and Strategies to Minimize Harm From Melanoma Diagnosis	13
Patterns of Atopic Eczema Disease Activity From Birth Through Midlife in 2 British Birth Cohorts	13
Evidence-Based Clinical Practice Guidelines for Laser-Assisted Drug Delivery	12
Improvement of Mortality Prognostication in Patients With Epidermal Necrolysis	12
Cutaneous Adverse Events and Cancer Survival Prognosis With Immune Checkpoint Inhibitor Treatment	12
Cost-Effectiveness Analysis of 3D Total-Body Photography for People at High Risk of Melanoma	12
Genetic Variants Associated With Hidradenitis Suppurativa	12
Complete Remission of Basal Cell Carcinoma Following Treatment With Cemiplimab After 2 Years	12
Incidence and Factors Associated With Second Primary Invasive Melanoma in Norway	12
Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children	12
Checklist for Evaluation of Image-Based Artificial Intelligence Reports in Dermatology	12
Risk of Hematologic Cancer in Patients With Undifferentiated Pruritus	12
Gene-Environment Interaction Between CYP1B1 and Oral Contraception on Frontal Fibrosing Alopecia	12
Olmsted Syndrome	12
Clinical Features and Outcomes of Black Patients With Melanoma	12
Clinical Associations of Degos-Like Lesions in Patients With Systemic Sclerosis	11
The Consideration of Cyclosporine in the Treatment of Stevens-Johnson Syndrome	11
Relevance of Human Herpesvirus 6 Reactivation in Drug Rash With Eosinophilia and Systemic Symptoms—Reply	11
Intralesional Certolizumab for Refractory Lupus Pernio	11
Intertriginous Xanthomas—Pathognomonic Cutaneous Markers of Homozygous Familial Hypercholesterolemia	11
Arc-Shaped Furrow on the Forehead Extending From Linear Alopecia on the Vertex	11
Cutaneous Anthrax	11
JAMA Dermatology	11
Genital and Perigenital “W”-Shaped Telangiectasias in Women With Limited Cutaneous Systemic Sclerosis	11
Perspectives on Use of the Cutaneous Direct Immunofluorescence Assay—Reply	11
Reanalysis of Study After Removal of Participants in 1 Trial of Upadacitinib for Atopic Dermatitis	11
Onychomycosis	11
JAMA Dermatology’s Commitment to Diversity, Equity, and Inclusion	10
Light-Related Cutaneous Symptoms of Erythropoietic Protoporphyria and Associations With Light Sensitivity Measurements	10
Evaluation of Clinical Relevance and Biological Effects of Antirituximab Antibodies in Patients With Pemphigus	10
Stigmatization and Mental Health Impact of Chronic Pediatric Skin Disorders	10
Factors Driving the Risk of Cognitive Impairment in Children With Atopic Dermatitis	10
Leprosy—Insufficient Evidence for Monthly Multidrug Therapy—Reply	10
Association Between Homelessness and Group A Streptococcus Skin and Soft Tissue Infections Among Hospitalized Dermatology Consult Patients	10
Sarcoidosis of the Skin	10
Risk of Alopecia Areata After COVID-19	10
Analysis of Specialist and Patient Perspectives on Strategies to Improve Cardiovascular Disease Prevention Among Persons With Psoriatic Disease	10
Botulinum Toxin A for the Treatment of Yellow Nail Syndrome and Palmar Primary Hyperhidrosis	10
Clinical Data on Laboratory Testing for Patients Taking Systemic Immunomodulatory Agents	10
Successful Treatment of Recalcitrant Mpox Lesions With Intralesional Cidofovir in a Patient With HIV/AIDS	10
Trichophyton mentagrophytes Internal Transcribed Spacer Genotype VIII	10
Improving Outcomes in Chronic Graft-vs-Host Disease	10
Why Increased Diversity in Dermatologic Clinical Trials Is Not Inherently Ethical—An Evidence-Based, Community-Engaged Approach to Diverse Trial Recruitment	10
Hunter Syndrome	10